Premium
PEMBROLIZUMAB WITH RCHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL AND GRADE 3B FOLLICULAR LYMPHOMA: FINAL RESULTS OF A PHASE I TRIAL
Author(s) -
Smith S.D.,
Lynch R.C.,
Till B.G.,
Cowan A.J.,
Wu Q.V.,
Voutsinas J.M.,
Shadman M.,
Shustov A.,
Cassaday R.D.,
Fromm J.R.,
Gopal A.K.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.80_2629
Subject(s) - medicine , rituximab , diffuse large b cell lymphoma , follicular lymphoma , vincristine , lymphoma , gastroenterology , rash , prednisone , cyclophosphamide , chemotherapy